Tonix Pharmaceuticals Holding Balance Sheet Health
Financial Health criteria checks 3/6
Tonix Pharmaceuticals Holding has a total shareholder equity of $74.2M and total debt of $8.0M, which brings its debt-to-equity ratio to 10.8%. Its total assets and total liabilities are $95.0M and $20.8M respectively.
Key information
10.8%
Debt to equity ratio
US$7.99m
Debt
| Interest coverage ratio | n/a |
| Cash | US$28.23m |
| Equity | US$74.21m |
| Total liabilities | US$20.78m |
| Total assets | US$94.99m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TNXP's short term assets ($50.5M) exceed its short term liabilities ($15.2M).
Long Term Liabilities: TNXP's short term assets ($50.5M) exceed its long term liabilities ($5.6M).
Debt to Equity History and Analysis
Debt Level: TNXP has more cash than its total debt.
Reducing Debt: TNXP's debt to equity ratio has increased from 0% to 10.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TNXP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TNXP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.6% each year